Compare
Sypris Solutions Inc vs Mesa Laboratories Inc vs Senseonics Holdings, Inc. vs Cognex Corp
| Latest fiscal year | Sypris Solutions Inc SYPR | Mesa Laboratories Inc MLAB | Senseonics Holdings, Inc. SENS | Cognex Corp CGNX |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2026-03-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $119.89M | $249.13M | $35.26M | $994.36M |
| Revenue growth (YoY) | -14.5% | +3.4% | +56.9% | +8.7% |
| Gross margin | 7.8% | 63.5% | 44.7% | 66.9% |
| Operating margin | -5.5% | 7.4% | -193.8% | 16.3% |
| Net margin | -5.3% | 2.7% | -196.0% | 11.5% |
| Net income | -$6.34M | $6.71M | -$69.11M | $114.44M |
| EPS (Diluted) | -$0.28 | $1.21 | -$1.66 | $0.68 |
| Operating cash flow | -$5.73M | $42.83M | -$59.13M | $245.51M |
| Free cash flow | -$6.49M | $39.58M | -$60.24M | $236.77M |
| Cash & equivalents | n/a | $26.93M | $40.23M | $262.93M |
| Total assets | $107.81M | $427.75M | $126.27M | $2.02B |
| Total liabilities | $90.02M | $241.50M | $65.22M | $524.65M |
| Shareholders' equity | $17.79M | $186.25M | $61.05M | $1.49B |
| Return on year-end equity | -35.6% | 3.6% | -113.2% | 7.7% |
| Shares outstanding | n/a | 5.52M | 41.27M | 167.00M |
Revenue, most recent five fiscal years
| Fiscal year | Sypris Solutions Inc | Mesa Laboratories Inc | Senseonics Holdings, Inc. | Cognex Corp |
|---|---|---|---|---|
| Latest | $119.89M Ended 2025-12-31 | $249.13M Ended 2026-03-31 | $35.26M Ended 2025-12-31 | $994.36M Ended 2025-12-31 |
| 1 year earlier | $140.18M Ended 2024-12-31 | $240.98M Ended 2025-03-31 | $22.47M Ended 2024-12-31 | $914.51M Ended 2024-12-31 |
| 2 years earlier | $136.22M Ended 2023-12-31 | $216.19M Ended 2024-03-31 | $22.39M Ended 2023-12-31 | $837.55M Ended 2023-12-31 |
| 3 years earlier | $110.12M Ended 2022-12-31 | $219.08M Ended 2023-03-31 | $16.39M Ended 2022-12-31 | $1.01B Ended 2022-12-31 |
| 4 years earlier | $97.43M Ended 2021-12-31 | $184.34M Ended 2022-03-31 | $13.68M Ended 2021-12-31 | $1.04B Ended 2021-12-31 |